Yup, apparently the dosing is still ongoing since Leo said the patient with 15 cycles remains enrolled in the trial. Could be more than one patient are involved in the advanced experimental phase.

Quote:

---

I say keep going. Although not statistically significant if only a single case, it is eye catching and would make for an excellent headline : "Phase I ovarian cancer patient still alive after ??? Number of months and exceeds the medium overall survival of Roche's Avastin + chemotherapy of 16.6 months in Phase 3."

---